Overview

Full Product Details

Author:   Yui-Wing Francis Lam (Professor of Pharmacology, Minnie Stevens Piper Professor, James O'Burke Endowed Centennial Fellow in Pharmacy, University of Texas Health Science Center, San Antonio, TX, USA) ,  Larisa H. Cavallari (PharmD, Associate Professor, Department of Pharmacy Practice, University of Illinois at Chicago)
Publisher:   Elsevier Science Publishing Co Inc
Imprint:   Academic Press Inc
Dimensions:   Width: 19.10cm , Height: 3.60cm , Length: 23.50cm
Weight:   1.200kg
ISBN:  

9780123919182

ISBN 10:   0123919185
Pages:   510
Publication Date:   14 March 2013
Audience:   Professional and scholarly ,  Professional & Vocational
Replaced By:   9780128126264
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

SECTION 1 1 Principles of Pharmacogenomics: Pharmacokinetic, Pharmacodynamic, and Clinical Implications 2 Translating Pharmacogenomic Research to Therapeutic Potentials 3 Governmental and Academic Efforts to Advance the Field of Pharmacogenomics (PGRN CPIC, PharmGKB) Section 2 4a Pharmacogenomics in Cancer Therapeutics 4b A Look to the Future: Cancer epigenetics 5a Pharmacogenomics in Cardiovascular Diseases 5b A Look to the Future: Cardiovascular Pharmaco-epigenetics 6a Pharmacogenomics in Psychiatry Disorders 6b A Look to the Future: Epigenetics in psychiatric disorders and treatment 7 Role of Pharmacogenomics in Diabetes and Other Therapeutic Areas SECTION 3 8a Molecular Approaches, Models, and Techniques in Pharmacogenomic Research and Development 8b Molecular Approaches, Models, and Techniques in Pharmacogenomic Research and Development 9a Incorporating Pharmacogenomics in Drug Development Part 1: Rational study designs for pharmacogenetic research and therapy - A perspective from academia 9b Incorporating Pharmacogenomics in Drug Development Part 2: A perspective from industry 10 Ethnobridging and Pharmacogenomics SECTION 4 11 Beyond ELSIs - Where to from here? From 'Regulator' to Anticipating and Shaping the Innovation Trajectory in Personalized Medicine 12 The Economics of Pharmacogenomics SECTION 5 13 Integrating Genomics into Pharmacy Education and Practice: Pharmacogenomics is not enough

Reviews

...a practical and indispensable resource on both the opportunities and challenges that allows readers to reflect on the future direction of pharmacogenomics while applying these observations to their own work or research. --Anticancer Research, February 2015 Lam and Cavallari bring together pharmacy and other specialists from North America, Europe, and Asia for 13 chapters aimed at scientists, clinicians, and students in health and pharmaceutical sciences. The chapters consider the translation of pharmacogenomic findings into therapeutic applications from academic, regulatory, pharmaceutical, clinical, socioethical, and economic perspectives. --Reference and Research Book News, August 2013 This book succeeds in providing a relevant and unique perspective, by international experts in the field, on the progress and challenges facing the translation of pharmacogenomics into clinical practice. I highly recommended it to anyone with an interest in the topic, from the essential basics to its role in the future practice of medicine. --Doody.com, August 2, 2013 ...this latest state-of-the-art book on pharmacogenomics successfully tackles the objectives described by its title. The key feature of the book is the in-depth discussion on a range of challenges currently facing pharmacogenomics in the widely publicised revolution in drug therapy... the Editors and the contributors are to be congratulated for their offering and this excellent book should serve well the needs of all those interested in the potential role of pharmacogenomic revolution in personalizing therapy... - British Journal of Clinical Pharmacology, November 5, 2013

This book succeeds in providing a relevant and unique perspective, by international experts in the field, on the progress and challenges facing the translation of pharmacogenomics into clinical practice. I highly recommended it to anyone with an interest in the topic, from the essential basics to its role in the future practice of medicine. --Doody.com, August 2, 2013

Author Information

Professor of Pharmacology, Department of Pharmacology and Associate Professor, Department of Medicine, The University of Texas Health Science Center at San Antonio Associate Professor, Department of Pharmacy Practice, University of Illinois at Chicago

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions